|
MPHOSPH8 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.84270000000731E-06 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.959500E-02 |
| Normal-vs-Stage2 |
1.050420E-01 |
| Normal-vs-Stage3 |
1.21590000290439E-08 |
| Normal-vs-Stage4 |
6.0924998379619E-10 |
| Stage1-vs-Stage2 |
7.531600E-01 |
| Stage1-vs-Stage3 |
4.1104000000014E-05 |
| Stage1-vs-Stage4 |
5.44149999948118E-07 |
| Stage2-vs-Stage3 |
2.922300E-02 |
| Stage2-vs-Stage4 |
9.521500E-03 |
| Stage3-vs-Stage4 |
5.278200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.06320000001514E-06 |
| Normal-vs-AfricanAmerican |
4.819500E-03 |
| Normal-vs-Asian |
9.494800E-01 |
| Caucasian-vs-AfricanAmerican |
8.746600E-01 |
| Caucasian-vs-Asian |
2.273000E-01 |
| AfricanAmerican-vs-Asian |
2.494600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.63810000026233E-07 |
| Normal-vs-Female |
4.282000E-03 |
| Male-vs-Female |
4.342300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.739580E-02 |
| Normal-vs-Age(41-60Yrs) |
1.638300E-03 |
| Normal-vs-Age(61-80Yrs) |
1.29709999996397E-06 |
| Normal-vs-Age(81-100Yrs) |
2.751600E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.925000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.759200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.865800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.582000E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.237400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.225400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.818100E-02 |
| Normal-vs-Grade 2 |
8.094000E-02 |
| Normal-vs-Grade 3 |
3.29729999970496E-08 |
| Normal-vs-Grade 4 |
1.02140518265514E-11 |
| Grade 1-vs-Grade 2 |
3.147900E-02 |
| Grade 1-vs-Grade 3 |
3.82960000000487E-05 |
| Grade 1-vs-Grade 4 |
8.78600000531193E-08 |
| Grade 2-vs-Grade 3 |
2.25549999999242E-05 |
| Grade 2-vs-Grade 4 |
1.97770000376352E-09 |
| Grade 3-vs-Grade 4 |
7.003000E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
6.564400E-01 |
| Normal-vs-ccB subtype |
1.77159997782894E-09 |
| ccA subtype-vs-ccB subtype |
3.99939970030516E-10 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.71990000000078E-05 |
| Normal-vs-N1 |
2.12349999995087E-06 |
| N0-vs-N1 |
5.045500E-02 |
|
|
